< Back to previous page
Patent
Respiratory syncytial virus vaccination
The present invention in general relates to novel respiratory syncytial virus (RSV) F nucleic acids and (glyco)proteins or peptides encoded therefrom. It further provides vaccines comprising such nucleic acids, (glyco)proteins or peptides, as well as uses thereof in the prophylaxis and/or treatment of RSV infections.
Patent Publication Number: WO2019063844
Year filing: 2019
Year approval: 2020
Year publication: 2019
Status: Requested
URI: link to Espacenet
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie Universiteit & Hogescholen Antwerpen